Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Albumin Market by Type (5% Concentrations, 25% Concentrations, Others), By Application (Therapeutics, Drug Formulation & Vaccine, Component of Media, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Albumin Market by Type (5% Concentrations, 25% Concentrations, Others), By Application (Therapeutics, Drug Formulation & Vaccine, Component of Media, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 299822 4200 Pharma & Healthcare 377 184 Pages 4.5 (45)
                                          

Market Overview:


The global human albumin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for human albumin in therapeutics, drug formulation & vaccine, and component of media applications. Additionally, the growing population and rising incidence of chronic diseases are also contributing to the growth of the global human albumin market. However, stringent regulatory norms and high cost associated with product manufacturing are restraining the growth of this market. On basis on type, 5% concentration segment is expected to account for majority share in terms revenue followed by 25% concentration segment over forecast period 2018-2030 owing higher adoption rate due its lower price point as compared 25% or greater concentrations products which offer better therapeutic outcomes but come at a premium price point hampering wider adoption rates across regions globally .Based on application ,Therapeutics sector is anticipated witness highest CAGR over forecast period owing increase use cases being developed and launched into clinics/hospitals worldwide whereas Drug Formulation & Vaccine sector would account second highest revenue share by 2030 end .


Global Human Albumin Industry Outlook


Product Definition:


Human albumin is a protein found in human blood. It is made up of 585 amino acids and has a molecular weight of 66,500 daltons. Human albumin functions as a transport protein, carrying other molecules throughout the bloodstream. It also helps to maintain the osmotic pressure of blood plasma and defends against infection. Albumin levels can be used to monitor how well the kidneys are functioning or to diagnose liver disease.


5% Concentrations:


5% concentration is the most preferred and widely used human albumin in China. It has a wide range of applications such as nutritional supplements, food & beverage, cosmetics, animal feed and pharmaceuticals. The market for 5% human albumin is expected to witness significant growth over the forecast period owing to increasing demand from various end-use industries including nutraceuticals and pharmaceuticals.


25% Concentrations:


25% concentrates are used in human albumin production. It is also used as a source of amino acids for animal feed and as a raw material for the production of pharmaceutical products. The market is expected to grow on account of increasing demand from the food & beverage industry, specifically from developing countries such as China, India, Brazil and South Africa.


Application Insights:


The therapeutics segment dominated the global human albumin market in 2017. This is attributed to rising usage of human proteins in the treatment of various diseases, such as diabetes and cardiovascular disorders. For instance, a clinical trial was conducted wherein diabetic patients were administered with recombinant human erythropoietin (rHuEPO) for 8 weeks. The study found that this therapy improved hemoglobin levels and reduced blood pressure in these patients [8].


Furthermore, another study reported that administration of recombinant Human Growth Hormone (rhGH) along with Insulin-like Growth Factor 1 (IGF-1) induced significant lean body mass gain in healthy elderly people [9]. These studies indicate the potential use of rhGH combined with IGF-1 for treating aging problems among adults. Such trends are expected to expand the scope for growth hormone therapy worldwide over the forecast period.


Regional Analysis:


North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period due to increasing prevalence of chronic diseases, such as cardiovascular, kidney and liver disorders. In addition, rising geriatric population is also anticipated to boost product demand in North America.


Asia Pacific human albumin market was valued at USD X billion in 2017 and is expected to witness lucrative growth over the forecast period owing to growing healthcare spending by governments along with an increase in awareness regarding chronic diseases among people especially young generation which accounts for a major part of population here. Also several multinational companies are investing huge amounts for research & development activities that will help them expand their business further into this region thus creating opportunities for market players over next seven years or so till 2030 AD (Approx.).


Growth Factors:


  • Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Chronic diseases are characterized by long-term symptoms and require ongoing treatment. As a result, there is a growing demand for therapies and treatments that can help manage these conditions effectively. Albumin therapy is one such treatment that has been shown to be effective in managing various chronic conditions, including renal failure, liver cirrhosis, and sepsis.
  • Growing awareness about the benefits of albumin therapy: There has been a growing awareness about the benefits of albumin therapy in recent years. This has led to an increase in demand for human albumin products among patients and healthcare professionals alike. Albumin therapy has been shown to be beneficial in treating various medical conditions, including dehydration, burns, shock syndrome, and cerebral edema. It also helps improve patient outcomes by reducing morbidity rates and hospital stays significantly

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Albumin Market Research Report

By Type

5% Concentrations, 25% Concentrations, Others

By Application

Therapeutics, Drug Formulation & Vaccine, Component of Media, Others

By Companies

CSL Behring, Grifols, Baxalta, Octapharma, Kedrion, CSL Behring

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

184

Number of Tables & Figures

129

Customization Available

Yes, the report can be customized as per your need.


Global Human Albumin Market Report Segments:

The global Human Albumin market is segmented on the basis of:

Types

5% Concentrations, 25% Concentrations, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Therapeutics, Drug Formulation & Vaccine, Component of Media, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. CSL Behring
  2. Grifols
  3. Baxalta
  4. Octapharma
  5. Kedrion
  6. CSL Behring

Global Human Albumin Market Overview


Highlights of The Human Albumin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 5% Concentrations
    2. 25% Concentrations
    3. Others
  1. By Application:

    1. Therapeutics
    2. Drug Formulation & Vaccine
    3. Component of Media
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Albumin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Human albumin is a protein that is found in the blood and other body tissues. Albumin helps to keep the blood fluid and healthy.

Some of the key players operating in the human albumin market are CSL Behring, Grifols, Baxalta, Octapharma, Kedrion, CSL Behring.

The human albumin market is expected to register a CAGR of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Albumin Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Human Albumin Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Human Albumin Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Human Albumin Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Human Albumin Market Size & Forecast, 2018-2028       4.5.1 Human Albumin Market Size and Y-o-Y Growth       4.5.2 Human Albumin Market Absolute $ Opportunity

Chapter 5 Global Human Albumin Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Human Albumin Market Size Forecast by Type
      5.2.1 5% Concentrations
      5.2.2 25% Concentrations
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Human Albumin Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Human Albumin Market Size Forecast by Applications
      6.2.1 Therapeutics
      6.2.2 Drug Formulation & Vaccine
      6.2.3 Component of Media
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Human Albumin Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Human Albumin Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Human Albumin Analysis and Forecast
   9.1 Introduction
   9.2 North America Human Albumin Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Human Albumin Market Size Forecast by Type
      9.6.1 5% Concentrations
      9.6.2 25% Concentrations
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Human Albumin Market Size Forecast by Applications
      9.10.1 Therapeutics
      9.10.2 Drug Formulation & Vaccine
      9.10.3 Component of Media
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Human Albumin Analysis and Forecast
   10.1 Introduction
   10.2 Europe Human Albumin Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Human Albumin Market Size Forecast by Type
      10.6.1 5% Concentrations
      10.6.2 25% Concentrations
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Human Albumin Market Size Forecast by Applications
      10.10.1 Therapeutics
      10.10.2 Drug Formulation & Vaccine
      10.10.3 Component of Media
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Human Albumin Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Human Albumin Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Human Albumin Market Size Forecast by Type
      11.6.1 5% Concentrations
      11.6.2 25% Concentrations
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Human Albumin Market Size Forecast by Applications
      11.10.1 Therapeutics
      11.10.2 Drug Formulation & Vaccine
      11.10.3 Component of Media
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Human Albumin Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Human Albumin Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Human Albumin Market Size Forecast by Type
      12.6.1 5% Concentrations
      12.6.2 25% Concentrations
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Human Albumin Market Size Forecast by Applications
      12.10.1 Therapeutics
      12.10.2 Drug Formulation & Vaccine
      12.10.3 Component of Media
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Human Albumin Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Human Albumin Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Human Albumin Market Size Forecast by Type
      13.6.1 5% Concentrations
      13.6.2 25% Concentrations
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Human Albumin Market Size Forecast by Applications
      13.10.1 Therapeutics
      13.10.2 Drug Formulation & Vaccine
      13.10.3 Component of Media
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Human Albumin Market: Competitive Dashboard
   14.2 Global Human Albumin Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details â€“ Overview, Financials, Developments, Strategy) 
      14.3.1 CSL Behring
      14.3.2 Grifols
      14.3.3 Baxalta
      14.3.4 Octapharma
      14.3.5 Kedrion
      14.3.6 CSL Behring

Our Trusted Clients

Contact Us